Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Pharma Analyst Assesses Impact of Looming Government Shutdown

FDA employees, drug developers, and patients have much to lose if drug approvals are stalled by months due to another shutdown.

FDA employees, drug developers, and patients have much to lose if drug approvals are stalled by months due to another shutdown.
FDA employees, drug developers, and patients have much to lose if drug approvals are stalled by months due to another shutdown.

Following the temporary halt on the U.S. government shutdown and the approaching deadline for a compromise to keep the government open, Dr. Jesus Cuaron, Managing Pharma Analyst at GlobalData, offered his view on how this has affected the FDA in this Feb. 1, 2019 statement:

“Throughout the longest federal government shutdown in U.S. history, federal agencies struggled to make sure that some, to most, oversight and guidance continued despite inadequate funding, including staffers not being paid.

“During the initial government shutdown, the FDA, tasked with protecting public health through oversight and regulation, began to shift its remaining 2018 funds towards usage in important 2019 drug approvals. However, if the federal government is forced to shut down once again, it is unlikely that the FDA will have the flexibility or backup funds required to deliver drug approvals in a timely manner.

“Whether or not the U.S. government will be shut down starting in mid-February is yet to be seen but it is hoped that a compromise can be found between Congress and the President to prevent it. In the meantime, FDA employees, drug developers, and patients have much to lose if drug approvals are stalled by months due to another shutdown.”

Read Eric Greenberg’s “Shutdown Starts up Thought” column here.

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging